A detailed history of Agf Management LTD transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Agf Management LTD holds 22,128 shares of SRPT stock, worth $2.69 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
22,128
Previous 20,940 5.67%
Holding current value
$2.69 Million
Previous $3.31 Million 16.48%
% of portfolio
0.01%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$124.33 - $156.75 $147,704 - $186,219
1,188 Added 5.67%
22,128 $2.76 Million
Q2 2024

Aug 07, 2024

BUY
$113.33 - $163.85 $485,959 - $702,588
4,288 Added 25.75%
20,940 $3.31 Million
Q1 2024

May 13, 2024

SELL
$93.7 - $141.53 $1.62 Million - $2.44 Million
-17,265 Reduced 50.9%
16,652 $2.16 Million
Q4 2023

Feb 07, 2024

BUY
$67.31 - $124.76 $2.28 Million - $4.23 Million
33,917 New
33,917 $3.27 Million

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10.6B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Agf Management LTD Portfolio

Follow Agf Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Agf Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Agf Management LTD with notifications on news.